$31.65
0.92.93%
At Close: -
$31.70
0.050.16%
After Hours: 4:14 PM EDT
15 minutes delayed
Alkami Technology
ALKTNASDAQ
want to know what
the Bulls & Bears Say?
Alkami Technology (NASDAQ:ALKT) Stock, Analyst Ratings, Price Targets, Forecasts
Alkami Technology Inc has a consensus price target of $27.71 based on the ratings of 14 analysts. The high is $40 issued by JP Morgan on December 14, 2021. The low is $20 issued by Citigroup on August 10, 2023. The 3 most-recent analyst ratings were released by Barclays, Needham, and Craig-Hallum on July 11, 2024, June 25, 2024, and May 2, 2024, respectively. With an average price target of $31.33 between Barclays, Needham, and Craig-Hallum, there's an implied -1.16% downside for Alkami Technology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Needham
Craig-Hallum
JMP Securities
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Alkami Technology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | Buy Now | -2.21% | Barclays | Saket Kalia | $28 → $31 | Maintains | Equal-Weight | Get Alert |
| 06/25/2024 | Buy Now | 0.95% | Needham | Mayank Tandon | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | Buy Now | -2.21% | Craig-Hallum | Jeff Van Rhee | $30 → $31 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | 0.95% | Needham | Mayank Tandon | $30 → $32 | Maintains | Buy | Get Alert |
| 04/15/2024 | Buy Now | -5.36% | JMP Securities | Patrick Walravens | → $30 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/29/2024 | Buy Now | -5.36% | JMP Securities | Patrick Walravens | $25 → $30 | Maintains | Market Outperform | Get Alert |
| 02/29/2024 | Buy Now | -2.21% | JP Morgan | Alexei Gogolev | $27 → $31 | Maintains | Overweight | Get Alert |
| 02/29/2024 | Buy Now | -14.83% | Barclays | Saket Kalia | $26 → $27 | Maintains | Equal-Weight | Get Alert |
| 02/29/2024 | Buy Now | -5.36% | Needham | Mayank Tandon | → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2024 | Buy Now | -14.83% | Goldman Sachs | Adam Hotchkiss | $23 → $27 | Maintains | Neutral | Get Alert |
| 01/23/2024 | Buy Now | -14.83% | Goldman Sachs | Adam Hotchkiss | $23 → $27 | Downgrade | Buy → Neutral | Get Alert |
| 01/08/2024 | Buy Now | -17.98% | Keybanc | Josh Beck | $21 → $26 | Maintains | Overweight | Get Alert |
| 01/05/2024 | Buy Now | -5.36% | Needham | Mayank Tandon | $24 → $30 | Maintains | Buy | Get Alert |
| 01/04/2024 | Buy Now | -17.98% | Barclays | Saket Kalia | $22 → $26 | Maintains | Equal-Weight | Get Alert |
| 12/07/2023 | Buy Now | -24.29% | Stephens & Co. | Charles Nabhan | → $24 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/03/2023 | Buy Now | -21.14% | JMP Securities | Patrick Walravens | $23 → $25 | Maintains | Market Outperform | Get Alert |
| 11/02/2023 | Buy Now | -33.75% | JP Morgan | Alexei Gogolev | $19 → $21 | Maintains | Overweight | Get Alert |
| 11/02/2023 | Buy Now | -24.29% | Needham | Mayank Tandon | $21 → $24 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | -36.91% | Citigroup | Andrew Schmidt | $19 → $20 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -40.06% | Keybanc | Josh Beck | $15 → $19 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | -33.75% | Needham | Mayank Tandon | $20 → $21 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | -40.06% | Barclays | Saket Kalia | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | -43.22% | Barclays | Saket Kalia | $14 → $18 | Maintains | Equal-Weight | Get Alert |
| 07/12/2023 | Buy Now | -33.75% | Goldman Sachs | Christopher Merwin | → $21 | Initiates | → Buy | Get Alert |
| 06/27/2023 | Buy Now | -33.75% | Lake Street | Jacob Stephan | → $21 | Initiates | → Buy | Get Alert |
| 06/08/2023 | Buy Now | -33.75% | Craig-Hallum | — | → $21 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | -52.68% | JP Morgan | Alexei Gogolev | → $15 | Initiates | → Overweight | Get Alert |
| 05/05/2023 | Buy Now | -40.06% | Citigroup | Andrew Schmidt | $22 → $19 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | -43.22% | Stephens & Co. | Charles Nabhan | → $18 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | Buy Now | -27.44% | JMP Securities | Patrick Walravens | → $23 | Reiterates | → Market Outperform | Get Alert |
| 04/13/2023 | Buy Now | -55.84% | Barclays | Saket Kalia | $17 → $14 | Maintains | Equal-Weight | Get Alert |
| 03/23/2023 | Buy Now | -52.68% | Keybanc | Josh Beck | $18 → $15 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | -30.6% | Citigroup | Andrew Schmidt | $18 → $22 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | -36.91% | Needham | Mayank Tandon | → $20 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | -43.22% | Keybanc | Josh Beck | $16 → $18 | Maintains | Overweight | Get Alert |
| 09/15/2022 | Buy Now | -43.22% | Stephens & Co. | Charles Nabhan | → $18 | Initiates | → Overweight | Get Alert |
| 08/04/2022 | Buy Now | -49.53% | Barclays | Saket Kalia | $15 → $16 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | -36.91% | Needham | Mayank Tandon | $17 → $20 | Maintains | Buy | Get Alert |
| 07/07/2022 | Buy Now | -43.22% | Keybanc | Josh Beck | $20 → $18 | Maintains | Overweight | Get Alert |
| 06/21/2022 | Buy Now | -43.22% | Citigroup | Andrew Schmidt | $32 → $18 | Maintains | Buy | Get Alert |
| 05/09/2022 | Buy Now | -52.68% | Barclays | Saket Kalia | $17 → $15 | Maintains | Equal-Weight | Get Alert |
| 05/06/2022 | Buy Now | -46.37% | Needham | Mayank Tandon | $22 → $17 | Maintains | Buy | Get Alert |
| 02/24/2022 | Buy Now | -30.6% | Needham | Mayank Tandon | $40 → $22 | Maintains | Buy | Get Alert |
| 01/25/2022 | Buy Now | -36.91% | Keybanc | Josh Beck | $35 → $20 | Maintains | Overweight | Get Alert |
| 01/19/2022 | Buy Now | -40.06% | Barclays | Saket Kalia | $33 → $19 | Maintains | Equal-Weight | Get Alert |
| 12/14/2021 | Buy Now | 26.18% | JP Morgan | Sterling Auty | — | Maintains | Overweight | Get Alert |
| 11/08/2021 | Buy Now | 10.41% | Keybanc | Josh Beck | — | Maintains | Overweight | Get Alert |
| 11/05/2021 | Buy Now | 26.18% | Needham | Mayank Tandon | — | Maintains | Buy | Get Alert |
| 10/13/2021 | Buy Now | 4.1% | Barclays | — | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Alkami Technology (ALKT) stock?
The latest price target for Alkami Technology (NASDAQ:ALKT) was reported by Barclays on July 11, 2024. The analyst firm set a price target for $31.00 expecting ALKT to fall to within 12 months (a possible -2.21% downside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alkami Technology (ALKT)?
The latest analyst rating for Alkami Technology (NASDAQ:ALKT) was provided by Barclays, and Alkami Technology maintained their equal-weight rating.
When was the last upgrade for Alkami Technology (ALKT)?
There is no last upgrade for Alkami Technology
When was the last downgrade for Alkami Technology (ALKT)?
The last downgrade for Alkami Technology Inc happened on January 23, 2024 when Goldman Sachs changed their price target from $23 to $27 for Alkami Technology Inc.
When is the next analyst rating going to be posted or updated for Alkami Technology (ALKT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkami Technology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkami Technology was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
Is the Analyst Rating Alkami Technology (ALKT) correct?
While ratings are subjective and will change, the latest Alkami Technology (ALKT) rating was a maintained with a price target of $28.00 to $31.00. The current price Alkami Technology (ALKT) is trading at is $31.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.